Sepsis in Patients Receiving Immunosuppressive Drugs in Korea: Analysis of the National Insurance Database from 2009 to 2013
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background: The aim of this study is to evaluate the influence of immunosuppressants on in-hospital mortality from sepsis. Methods: Using data of the Health Insurance Review & Assessment Service, we collected data from patients who were admitted to the hospital due to sepsis from 2009 to 2013. Based on drugs commonly used for immunosuppression caused by various diseases, patients were divided into three groups; immunosuppressant group, steroid-only group, and control group. Patients with no history of immunosuppressants or steroids were assigned to the control group. To identify risk factors of in-hospital mortality in sepsis, we compared differences in patient characteristics, comorbidities, intensive care unit (ICU) care requirements, and immunodeficiency profiles. Subgroup analysis according to age was also performed. Results: Of the 185,671 included patients, 13,935 (7.5%) were in the steroid-only group and 2,771 patients (1.5%) were in the immunosuppressant group. The overall in-hospital mortality was 38.9% and showed an increasing trend with age. The steroid-only group showed the lowest in-hospital mortality among the three groups except the patients younger than 30 years. The steroid-only group and immunosuppressant group received ICU treatment more frequently (p < 0.001), stayed longer in the hospital (p < 0.001), and showed higher medical expenditure (p < 0.001) compared to the normal group. Univariate and multivariate analyses revealed that age, male gender, comorbidities (especially malignancy), and ICU treatment had a significant effect on in-hospital mortality. Conclusions: Despite longer hospital length of stay and more frequent need for ICU care, the in-hospital mortality was lower in patients taking immunosuppressive drugs than in patients not taking immunosuppressive drugs.
Abstract
Background: The aim of this study is to evaluate the influence of immunosuppressants on in-hospital mortality from sepsis. Methods: Using data of the Health Insurance Review & Assessment Service, we collected data from patients who were admitted to the hospital due to sepsis from 2009 to 2013. Based on drugs commonly used for immunosuppression caused by various diseases, patients were divided into three groups; immunosuppressant group, steroid-only group, and control group. Patients with no history of immunosuppressants or steroids were assigned to the control group. To identify risk factors of in-hospital mortality in sepsis, we compared differences in patient characteristics, comorbidities, intensive care unit (ICU) care requirements, and immunodeficiency profiles. Subgroup analysis according to age was also performed. Results: Of the 185,671 included patients, 13,935 (7.5%) were in the steroid-only group and 2,771 patients (1.5%) were in the immunosuppressant group. The overall in-hospital mortality was 38.9% and showed an increasing trend with age. The steroid-only group showed the lowest in-hospital mortality among the three groups except the patients younger than 30 years. The steroid-only group and immunosuppressant group received ICU treatment more frequently (p < 0.001), stayed longer in the hospital (p < 0.001), and showed higher medical expenditure (p < 0.001) compared to the normal group. Univariate and multivariate analyses revealed that age, male gender, comorbidities (especially malignancy), and ICU treatment had a significant effect on in-hospital mortality. Conclusions: Despite longer hospital length of stay and more frequent need for ICU care, the in-hospital mortality was lower in patients taking immunosuppressive drugs than in patients not taking immunosuppressive drugs.
참고문헌 (30)
- Castellanos-Ortega A, "Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study", Crit Care Med, 38, pp.1036~1043 (2010)
- Dellinger RP, "Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012", Intensive Care Med, 39, pp.165~228 (2013)
- Shiramizo SC, "Decreasing mortality in severe sepsis and septic shock patients by implementing a sepsis bundle in a hospital setting", PLoS One, 6, pp.e26790~ (2011)
- Dellinger RP, "Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008", Crit Care Med, 36, pp.296~327 (2008)
- Leentjens J, "Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?", Am J Respir Crit Care Med, 187, pp.1287~1293 (2013)
- Galbois A, "Improved prognosis of septic shock in patients with cirrhosis: a multicenter study", Crit Care Med, 42, pp.1666~1675 (2014)
- Brun-Buisson C, "Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis", JAMA, 274, pp.968~974 (1995)
- Linden PK, "Approach to the immunocompromised host with infection in the intensive care unit", Infect Dis Clin North Am, 23, pp.535~556 (2009)
- Weiss SL, "Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis", Crit Care Med, 42, pp.2409~2417 (2014)
- Kroschinsky F, "Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies", Intensive Care Med, 28, pp.1294~1300 (2002)
- Japiassú AM, "Sepsis is a major determinant of outcome in critically ill HIV", AIDS patients, 2010, pp.14, R152~
- Choi NK, "Signal detection of rosuvastatin compared to other statins: data-mining study using national health insurance claims database", Pharmacoepidemiol Drug Saf, 19, pp.238~246 (2010)
- Koo BK, "The incidence and prevalence of diabetes mellitus and related atherosclerotic complications in Korea: a National Health Insurance Database Study", PLoS One, 9, pp.e110650~ (2014)
- Shen HN, "Epidemiologic trend of severe sepsis in Taiwan from 1997 through 2006", Chest, 138, pp.298~304 (2010)
- Kumar G, "Nationwide trends of severe sepsis in the 21st century (2000-2007)", Chest, 140, pp.1223~1231 (2011)
- Kübler A, "Results of the severe sepsis registry in intensive care units in Poland from 2003-2009", Anaesthesiol Intensive Ther, 47, pp.7~13 (2015)
- Bouza E, "Fever of unknown origin in solid organ transplant recipients", Infect Dis Clin North Am, 21, pp.1033~1054 (2007)
- Kieslichova E, "The effect of immunosuppression on manifestations of sepsis in an animal model of cecal ligation and puncture", Transplant Proc, 45, pp.770~777 (2013)
- Tolsma V, "Sepsis severe or septic shock: outcome according to immune status and immunodeficiency profile", Chest, 146, pp.1205~1213 (2014)
- Schäcke H, "Mechanisms involved in the side effects of glucocorticoids", Pharmacol Ther, 96, pp.21~43 (2002)
- Buttgereit F, "Optimised glucocorticoid therapy: the sharpening of an old spear", Lancet, 365, pp.801~803 (2005)
- Senderovitz T, "Corticosteroids and tuberculosis", Respir Med, 88, pp.561~565 (1994)
- Cline JC, "Risks of infection or reactivation of tuberculosis associated with chronic corticosteroid therapy", Ann Pharmacother, 31, pp.775~776 (1997)
- Kennedy WA, "Occurrence and risk factors of oral candidiasis treated with oral antifungals in seniors using inhaled steroids", J Clin Epidemiol, 53, pp.696~701 (2000)
- Girardin E, "Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura", N Engl J Med, 319, pp.397~400 (1988)
- Hotchkiss RS, "The pathophysiology and treatment of sepsis", N Engl J Med, 348, pp.138~150 (2003)
- Ferrer R, "Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guidelinebased performance improvement program", Crit Care Med, 42, pp.1749~1755 (2014)
- Yokota PK, "Impact of appropriate antimicrobial therapy for patients with severe sepsis and septic shock--a quality improvement study", PLoS One, 9, pp.e104475~ (2014)
- Poutsiaka DD, "Risk factors for death after sepsis in patients immunosuppressed before the onset of sepsis", Scand J Infect Dis, 41, pp.469~479 (2009)
- Dombrovskiy VY, "Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003", Crit Care Med, 35, pp.1244~1250 (2007)